Multiple Sclerosis
Magnetic Molecular Energizing (MME) has
been used effectively for Multiple Sclerosis.
MME treatment is considered
investigational and is utilized under the direction and auspices of an
Investigational Review Board (IRB). The IRB complies with FDA
requirements for investigational therapy usage and results review. MME
therapy is safe and non-invasive. In some cases, patients may experience
some tingling, however, most experience no ill effects and can talk,
sleep, read or watch TV.
Facts about Multiple Sclerosis
-
Approximately
400,000 people have Multiple Sclerosis in the U.S. It occurs between
the ages of 20 and 50 and women are 3 times more to likely to develop
MS than men.
- It is a disease that affects all nerve tissue including brain,
spinal cord and central and peripheral nerves. The covering of the
nerves is called myelin and this becomes destroyed or damaged
impairing the electrical impulses along nerves to muscles.
- Multiple Sclerosis commonly has flare ups followed by total
recovery. This is a commonly presenting history. Other patients have
worsening symptoms without any recovery.
- Common symptoms are distortion of vision, pins and needles in any
area, abnormal gait, fatigue, dizziness, bowel or bladder symptoms,
spasticity in arms and legs, depression and motor function
abnormalities.
Treatment and Case Results
Initial treatment includes medication combinations including drugs
affecting the immune system and physical rehab.
N.S. is a 73 year old lady with an established
diagnosis of M.S. of several years duration after an MRI and spinal
fluid analysis. She complains of spasticity in the left leg and
weakness of the right leg, extreme fatigue, overall motor weakness and
a staggering gait. She completes 275 hours of MME. She indicated a
marked improvement in flexibility and much less fatigue. She also
states increased strength in legs. After 1 year, she indicated
maintained ability to function daily without fatigue.
D.S. is a 42 year old female with MS complaining of
weakness in leg strength, upper extremity numbness and marked fatigue.
She also indicated an inability to drive due to inability to focus her
eyes. After 287 hours of MME exposure she reported a 40 – 60%
improvement in every symptom, especially improved vision and loss of
fatigue.
Although no absolute assurances can be
given, there is good reason for optimism for benefit, in individuals who
are accepted for treatment, after review and screening. MME appears to
enhance and speed the healing of tissues at the cellular and molecular
level.
|